EdgarLookup

Sunshine Biopharma Inc. — All Filings

379 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-KT 10-Q 10-Q/A 10KSB 10KSB/A 10QSB 10QSB/A 3 3/A 4 4/A 424B3 424B4 424B5 8-A12B 8-A12G 8-K 8-K/A CERT CORRESP D DEF 14A DEF 14C DEFA14A DEFR14C DEL AM EFFECT NT 10-K NT 10-Q POS AM PRE 14A PRE 14C REGDEX RW S-1 S-1/A S-3 S-4 S-8 SB-2 SC 13G SC 13G/A SC 14F1 SCHEDULE 13G SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
8-K FORM 8-K 0001683168-24-005496 Aug 12, 2024 Aug 7, 2024
DEF 14C DEFINITIVE PROXY 0001683168-24-004755 Jul 11, 2024 Jun 28, 2024
8-K FORM 8-K 0001683168-24-004601 Jul 2, 2024 Jun 28, 2024
PRE 14C FORM PRE 14C 0001683168-24-004574 Jul 1, 2024
8-K FORM 8-K 0001683168-24-004572 Jul 1, 2024 Jun 28, 2024
8-K CURRENT REPORT 0001683168-24-004120 Jun 11, 2024
8-K FORM 8-K 0001683168-24-004053 Jun 7, 2024
8-K FORM 8-K 0001683168-24-003777 May 22, 2024 May 21, 2024
10-Q FORM 10-Q FOR MARCH 2024 0001683168-24-003688 May 20, 2024 Mar 31, 2024
NT 10-Q EXTENSION 0001683168-24-003460 May 15, 2024 Mar 31, 2024
8-K FORM 8-K 0001683168-24-003104 May 8, 2024 May 7, 2024
8-K FORM 8-K 0001683168-24-003004 May 6, 2024 May 3, 2024
8-K FORM 8-K 0001683168-24-002616 Apr 23, 2024 Apr 17, 2024
8-K CURRENT REPORT 0001683168-24-001993 Apr 1, 2024
10-K FORM 10-K FOR FYE END DEC 2023 0001683168-24-001818 Mar 28, 2024 Dec 31, 2023
DEF 14C DEFINITIVE INFORMATION STATEMENT 0001683168-24-001487 Mar 15, 2024 Mar 20, 2024
8-K FORM 8-K 0001683168-24-001357 Mar 6, 2024 Mar 4, 2024
PRE 14C PRELIMINARY INFORMATION STATEMENT 0001683168-24-001323 Mar 5, 2024
4 0001683168-24-001322 Mar 5, 2024 Mar 4, 2024
DEF 14C FORM DEF 14C 0001683168-24-001285 Mar 5, 2024 Mar 8, 2024
8-K FORM 8-K 0001683168-24-001253 Mar 1, 2024 Feb 28, 2024
SC 13G SCHEDULE 13G 0001079973-24-000295 Feb 23, 2024
PRE 14C PRE 14C 0001683168-24-001090 Feb 21, 2024
SC 13G SCHEDULE FILED TO REPORT ACQUISTION OF BENEFICAL OWNERSHIP 0001999371-24-002586 Feb 21, 2024
8-K FORM 8-K 0001683168-24-001049 Feb 16, 2024 Feb 13, 2024
8-K CURRENT REPORT 0001683168-24-001009 Feb 15, 2024 Feb 13, 2024
SC 13G 0001172661-24-001404 Feb 14, 2024
424B4 424B4 0001683168-24-000953 Feb 14, 2024
EFFECT 9999999995-24-000394 Feb 12, 2024
4 0001683168-24-000879 Feb 12, 2024 Feb 8, 2024
8-K FORM 8-K 0001683168-24-000865 Feb 12, 2024 Feb 11, 2024
CORRESP 0001683168-24-000853 Feb 9, 2024
3 0001683168-24-000800 Feb 9, 2024 Jan 26, 2024
S-1/A AMENDMENT NO. 1 TO FORM S-1 0001683168-24-000849 Feb 9, 2024
CORRESP 0001683168-24-000852 Feb 9, 2024
UPLOAD 0000000000-24-001460 Feb 6, 2024
S-1 REGISTRATION STATEMENT 0001683168-24-000610 Feb 1, 2024
8-K CURRENT REPORT 0001683168-24-000540 Jan 30, 2024 Jan 25, 2024
S-8 S-8 0001683168-24-000105 Jan 8, 2024
8-K FORM 8-K 0001683168-23-008696 Dec 7, 2023
10-Q FORM10-Q FOR SEPT 2023 0001683168-23-007911 Nov 13, 2023 Sep 30, 2023
8-K FORM 8-K 0001683168-23-007924 Nov 13, 2023
8-K FORM 8-K 0001683168-23-007582 Nov 2, 2023
8-K CURRENT REPORT 0001683168-23-007302 Oct 20, 2023 Oct 18, 2023
DEFA14A ADDITIONAL SOLICITING MATERIALS 0001683168-23-007272 Oct 19, 2023
DEF 14A DEFINITIVE PROXY STATEMENT 0001683168-23-007244 Oct 18, 2023 Dec 7, 2023
8-K FORM 8-K 0001683168-23-007129 Oct 13, 2023 Oct 12, 2023
8-K CURRENT REPORT 0001683168-23-006611 Sep 22, 2023 Sep 21, 2023
DEF 14A DEF 14A 0001683168-23-006264 Sep 5, 2023 Oct 12, 2023
UPLOAD 0000000000-23-009534 Aug 29, 2023